The immunomodulatory effect of bone marrow stromal cells (BMSCs) on interleukin (IL)-23/IL-17-mediated ischemic stroke in mice
Authors:
- Di ZhongDZDi Zhong
- Hongping ChenHCHongping Chen
- Yi ZhengYZYi Zheng
- Yanyan SunYSYanyan Sun
- Jian LuoJLJian Luo
- Hulun LiHLHulun Li
- Guozhong LiGLGuozhong Li
- Yanhong YinYYYanhong Yin
- 1 April 2013
- journal article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 257 (1-2) , 28-35
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation (30971015)
- Harbin Science and Technology Innovation Talents of Special Fund Project (2009RFXXS021)
This publication has 31 references indexed in Scilit:
- New concepts on the immune modulation mediated by mesenchymal stem cellsStem Cell Research & Therapy, 2010
- New Era of Cell-Based Orthopedic TherapiesTissue Engineering Part B: Reviews, 2009
- Th17 Cells and Autoimmune Encephalomyelitis (EAE/MS)Allergology International, 2008
- Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitisJournal of Clinical Investigation, 2006
- Intracerebral xenografts of mouse bone marrow cells in adult rats facilitate restoration of cerebral blood flow and blood–brain barrierBrain Research, 2004
- Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brainNature, 2003
- Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuliBlood, 2002
- Therapeutic Benefit of Intravenous Administration of Bone Marrow Stromal Cells After Cerebral Ischemia in RatsStroke, 2001
- Inflammatory Mediators and Stroke: New Opportunities for Novel TherapeuticsJournal of Cerebral Blood Flow & Metabolism, 1999
- Apoptosis and Necrosis after Reversible Focal Ischemia: An in Situ DNA Fragmentation AnalysisJournal of Cerebral Blood Flow & Metabolism, 1996